SURF Surface Oncology Inc

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.

$7.94  -0.24 (-2.88%)
As of 04/09/2021 15:59:25 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/19/2018
Outstanding shares:  41,727,725
Average volume:  2,072,127
Market cap:   $331,735,414
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    86877M209
ISIN:        US86877M2098
Sedol:      BZ57GY6
Valuation   (See tab for details)
PE ratio:   4.47
PB ratio:   2.08
PS ratio:   2.63
Return on equity:   38.10%
Net income %:   47.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy